Resultado da Busca
ESMO has Clinical Practice Guidelines on the following Gastrointestinal Cancers: Rectal Cancer, Biliary cancer, Gastric cancer, Oesophageal cancer, Pancreatic cancer, Metastatic colorectal cancer, Anal cancer, Early colon cancer, Familial risk colorectal cancer, Hepatocellular carcinoma.
- Gastrointestinal Cancers: Pancreatic Cancer in The Covid-19 Era
The tiered approach of ESMO in delivering a guidance for...
- Gastrointestinal Cancers: Gastro-oesophageal Tumours in The Covid-19 Era
Patients with clinical cT1N0: consider endoscopic resection...
- Pan-Asian Adaptation
It was therefore decided, by both the ESMO and the Japanese...
- Metastatic Colorectal Cancer
A. Cervantes, R. Adam, S. Roselló, et al, on behalf of the...
- Gastric Cancer
ESMO for World Cancer Day 2024; ESMO for World Cancer Day...
- Anal Cancer
Authors: S. Rao, M. G. Guren, K. Khan, G. Brown, A. G....
- Hepatocellular Carcinoma
COVID-19 and cancer care in the ESMO journals; ESMO Brand....
- Guidelines Webinar
Audit the fulfillment of the learning objectives and...
- Gastrointestinal Cancers: Pancreatic Cancer in The Covid-19 Era
25 de out. de 2022 · This ESMO Clinical Practice Guideline provides key recommendations for managing metastatic colorectal cancer. It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 Jan;34 (1):10-32. doi: 10.1016/j.annonc.2022.10.003. Epub 2022 Oct 25.
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Incidence and epidemiology. The incidence of rectal cancer in the European Union is ∼125 000 per year, i.e. ∼35% of the total colorectal cancer incidence, reflecting 15–25 cases/100 000 population per year and is predicted to increase further in both genders.
- Bengt Glimelius, Lars Påhlman, A. Cervantes
- 2010
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016 Aug;27 (8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5. Authors.
- E. Van Cutsem, A. Cervantes, R. Adam, A. Sobrero, J.H.J.M. van Krieken, D. Aderka, E. Aranda Aguilar...
- 2016
24 de mai. de 2023 · The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer (mCRC), published in late 2022, were adapted in December 2022, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guid...
5 de jul. de 2021 · Introduction. Colon cancer (CC) is the third most common tumor globally and the fourth leading cause of death accounting for >600 000 deaths estimated each year. Currently, patient management and clinical outcome prediction are still entirely defined according to histopathological evaluation.
